Smart Inhalers in Paediatric Asthma Care: Opportunities and Challenges

Strategic Insights -

A recent study highlights the potential of smart inhaler systems in transforming paediatric asthma care by addressing fundamental problems affecting asthma outcomes, including medication adherence, inhalation technique, and reliever overuse. The research outlines key categories of smart inhalers and summarises the current evidence surrounding their use in children. However, technical limitations, behavioural factors, and health system-level challenges hinder the widespread clinical adoption of these technologies. Establishing clear quality standards, defining appropriate indications, achieving better integration of smart inhaler data, and generating robust cost-effectiveness data are essential to support the clinical adoption of smart inhalers.

Key Takeaways:

  • Smart inhaler systems have the potential to transform paediatric asthma care by addressing medication adherence, inhalation technique, and reliever overuse.
  • The main categories of smart inhalers include digital dose counters, smart spacers, and smart nebulisers.
  • A review of the current evidence surrounding the use of smart inhalers in children is critical to understanding their potential benefits and limitations.
  • Key obstacles to the implementation of smart inhaler systems include technical limitations, behavioural factors, and health system-level challenges.
  • Establishing clear quality standards for smart inhaler systems is essential to supporting their widespread clinical adoption.
  • Defining appropriate indications for the use of smart inhaler systems and generating robust cost-effectiveness data are also critical to their adoption.
  • The integration of smart inhaler data into electronic healthcare records is essential to support the effective use of these technologies.
  • The development of smart inhaler systems that are user-friendly and easy to integrate into clinical practice is crucial to their adoption.
  • The use of smart inhalers in paediatric asthma care has the potential to improve asthma outcomes and reduce healthcare costs.

Statistics:

  • According to the research, medication adherence is a critical problem affecting paediatric asthma outcomes.
  • The use of smart nebulisers has been shown to improve medication adherence and reduce asthma symptoms.
  • A study published in the Paediatric Respiratory Reviews journal found that the use of digital dose counters improved medication adherence in children with asthma.
  • The integration of smart inhaler data into electronic healthcare records has the potential to reduce healthcare costs and improve asthma outcomes.
  • The development of smart inhaler systems that are user-friendly and easy to integrate into clinical practice is crucial to their adoption.

Sources:

  • "Smart inhalers in paediatric asthma: bridging the gap between innovation and clinical practice." Paediatric Respiratory Reviews, 2025.
  • Universite Paris Cite, Inserm UMR 1346, Inria, HeKA Team, PariSante Campus, Paris, France.
  • Job F. M. van Boven, Boudewijn J. H. Dierick, Ireti Adejumo, William Carroll, Heather De Keyser, Erol A. Gaillard, and Amy Chan.
  • Elsevier Sci Ltd, 125 London Wall, London, England.
  • NewsRx. Reports on Asthma from Universite Paris Cite Provide New Insights (Smart inhalers in paediatric asthma: bridging the gap between innovation and clinical practice). Respiratory Therapeutics Week. October 20, 2025; p 463.